KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,802,411 | -22.3% | 176,252 | -0.3% | 1.75% | -18.0% |
| Q2 2023 | $38,344,818 | +803.1% | 176,826 | +656.5% | 2.13% | +12.9% |
| Q1 2023 | $4,245,835 | +22.1% | 23,375 | +32.1% | 1.89% | +12.0% |
| Q4 2022 | $3,478,050 | -12.6% | 17,700 | 0.0% | 1.69% | -15.0% |
| Q3 2022 | $3,981,000 | +63.0% | 17,700 | -8.3% | 1.99% | +83.5% |
| Q2 2022 | $2,442,000 | +8.2% | 19,300 | +8.4% | 1.08% | +41.4% |
| Q1 2022 | $2,257,000 | -10.3% | 17,800 | -7.3% | 0.76% | +5.5% |
| Q4 2021 | $2,515,000 | – | 19,200 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |